Skip to main content

Day: April 28, 2022

Baltic Horizon Fund declares quarterly cash distribution of approx. EUR 1.56 million to investors

Northern Horizon Capital AS as the management company of Baltic Horizon Fund (the Fund) has approved a cash distribution of approx. 1.17% of the Fund’s Q1 2022 weighted average net asset value to its unitholders. This equals approx. EUR 1.56 million in total and EUR 0.013 per unit. The pay-out represents an increased rolling distribution yield of 6.3% for the past 12 months based on the closing unit price on the last day of Q1 2022 on the Nasdaq Tallinn stock exchange. In Q1 2022, the Fund generated an unaudited Generated Net Cash Flow (GNCF) from operations of approx. EUR 1.9 million. The Fund aims to have the distribution rate at 80% of quarterly GNCF and reinvest the remaining 20% into ongoing projects to boost future cash flows and property values. In total, the Fund has paid out EUR 7.18 million from the operating results of the...

Continue reading

National Seating & Mobility Awarded Home Care Accreditation from The Joint Commission

National Seating & Mobility announced that the company has again earned The Joint Commission’s Gold Seal of Approval® for Home Care Accreditation by demonstrating continuous compliance with its performance standards. NASHVILLE, Tenn., April 28, 2022 (GLOBE NEWSWIRE) — National Seating & Mobility (NSM), North America’s largest provider of comprehensive mobility solutions, announced that the company has again earned The Joint Commission’s Gold Seal of Approval® for Home Care Accreditation by demonstrating continuous compliance with its performance standards. The Gold Seal is a symbol of quality that reflects a health care organization’s commitment to providing safe and quality patient care. “NSM is proud to be awarded Home Care re-accreditation from The Joint Commission,” said Bill Mixon, NSM CEO. “This honor reflects...

Continue reading

Quantum Genomics Publishes its Results for Fiscal Year 2021 and Provides a Corporate Update

PARIS, April 28, 2022 (GLOBE NEWSWIRE) — Quantum Genomics (Euronext Growth – FR0011648971 – ALQGC), a biopharmaceutical company specialising in the development of a new class of medicinal products that act directly on the brain in order to address difficult-to-treat/resistant hypertension and heart failure, today reported its full year 2021 results. The annual financial statements were approved by the Board of Directors on 27 April 2022. Statutory auditor’s report is available on the Company’s website: www.quantum-genomics.com. The “Document d’Enregistrement Universel” including the financial report for fiscal year 2021 will be available on the company’s website in the coming days. Jean-Philippe Milon, CEO of Quantum Genomics, said: “In an environment still impacted by the pandemic crisis, we continued our research...

Continue reading

LECTRA: Q1 2022: strong growth in orders, revenues and earnings

Q1 2022: strong growth in orders, revenues and earningsRevenues: 122.0 million euros (+83%) EBITDA before non-recurring items: 21.6 million euros (+90%) Net income: 9.3 million euros (+55%) Free cash flow before non-recurring items: 7.1 million eurosin millions of euros January 1 – March 31  2022 2021Revenues 122.0 66.7Change (%) +83%  EBITDA before non-recurring items(1) 21.6 11.4Change (%) +90%  EBITDA margin before non-recurring items (in % of revenues) 17.7% 17.0%Net income 9.3 6.0Change (%) +55%  Free cash flow before non-recurring items(1) 7.1 9.8         (1)  The definition of the performance indicators is illustrated in the Financial Report at March 31, 2022 Paris, April 28, 2022. Today, Lectra’s Board of Directors, chaired by Daniel Harari, reviewed the unaudited consolidated financial statements...

Continue reading

Velcan Holdings: Annual Results 2021

PRESS RELEASE Luxembourg, 28th April 2022 VELCAN HOLDINGS: ANNUAL RESULTS 2021 GOOD FINANCIAL RESULTS, NET INCOME AND EBITDA AFFECTED BY A LARGE PROVISION ON THE INDIAN HYDROPOWER PROJECTSNON-AUDITED KEY CONSOLIDATED FIGURES 2021 2020 Var %Revenues (EUR m) 2.4 2.5 –4%EBITDA (EUR m) –5.6 -2.0 –176%Net Income (EUR m) 6.5 2.1 +205%Cash and Financial assets and liabilities 120 105 +15%Shareholders’ Equity (EUR m) 122 116 +5%With the US and Chinese market experiencing a rebound with the support of the FED and increased vaccination campaigns, the Group positions in equity and commodities (the latter mostly oil and gold related) have on average performed well in 2021, which ended with a significant financial result of EUR 21.0m (+173%), compared to EUR 7.7m at the end of 2020. This was contrasted by a...

Continue reading

LECTRA: Q1 2022 financial report available

Q1 2022 financial report available Paris, April 28, 2022 – Lectra informs its shareholders, in compliance with Article 221-4-IV of the General Regulation of the Autorité des marchés financiers, that the Management Discussion and Analysis of Financial Condition and Results of Operations for the first quarter 2022 is available on the company’s website: www.lectra.com It is also available, upon request, by email: investor.relations@lectra.com About Lectra: As a major player in the fashion, automotive and furniture markets, Lectra contributes to the Industry 4.0 revolution with boldness and passion by providing best-in-class technologies.The Group offers industrial intelligence solutions – software, equipment, data and services – that facilitate the digital transformation of the companies it serves. In doing so, Lectra helps...

Continue reading

Umicore on track for a strong 2022 performance

Umicore on track for a strong 2022 performanceUmicore recorded a strong performance across all of its business groups in the first quarter in a volatile market context, despite rising cost inflation. The Catalysis business group delivered a strong performance in the first quarter, albeit and as anticipated below a very strong first quarter last year and against an increasingly challenging backdrop. Car production has been negatively impacted by supply disruptions caused by ongoing semiconductor shortages, the conflict in Ukraine and more recently strict COVID-lockdowns in major Chinese cities. Umicore outperformed the car market benefiting from its strong market position and customer exposure in gasoline catalyst applications. In the heavy-duty diesel segment, Umicore’s volumes declined in the Chinese market. As anticipated, the heavy-duty...

Continue reading

Coface records a strong start to the year with a net income of €66.2m

Coface records a strong start to the year with a net income of €66.2m Paris, 28 April 2022 – 17.35Turnover: €431m, up 12.8% at constant FX and perimeterTrade Credit Insurance premiums growing by 14.7% at constant FX driven by high client activity Client retention at record highs (94.8%); pricing impact negative (-2.7%) Information services continued to grow (+11.0% at constant FX)Net loss ratio at 40.7% and net combined ratio at 67.3% (respectively 30.4% and 55.3% excluding government schemes)Gross loss ratio at 28.9%, improved by 0.6 ppt Net cost ratio down by -1.7 ppt at 26.6% reflecting operating leverage and higher reinsurance commissions Government schemes have lowered pre-tax profit by €33m for the quarter (€199m cumulated); no further material impact expected going forwardNet income (group share) at €66.2m, up by +17.5%...

Continue reading

RAMSAY SANTE : 9 months results, at the end of 31st March 2022

PRESS RELEASEParis, 28 April 2022 Strong organic revenues growth confirming the relevance of our patient pathway strategy despite the ongoing headwinds linked to the COVID situation and the staff shortageUnaudited turnover for the 9 months period ending 31 March 2022 amounted to €3,141.7m, up 6.7% compared to the same period of the previous year. Unaudited turnover for the 3 months period ending 31 March 2022 amounted to €1,104m, up 6,9% compared to the same period of the previous year. Unaudited EBITDA for the 9 months period ending 31 March 2022 amounted to €502,9m, up 15,7% compared to the same period of the previous year. Unaudited EBITDA for the 3 months period ending 31 March 2022 amounted to €167,5m, up 37,2% compared to the same period of the previous year. Unaudited EBIT for the 9 months period ending 31 March 2022 amounted...

Continue reading

Morris State Bancshares Announces Quarterly Earnings, Declares Second Quarter Dividend and Announces new Chairman and Lead Director

DUBLIN, Ga., April 28, 2022 (GLOBE NEWSWIRE) — Morris State Bancshares, Inc. (OTCQX: MBLU) (the “Company”), the parent of Morris Bank, today announced net income of $5.2 million for the quarter ending March 31, 2022. This level was in line with the first quarter of 2021’s net income of $5.2 million and below record-level net income of $7.1 million in the fourth quarter of 2021. Tangible book value of the company grew to $66.98 on March 31, 2022, from $56.77, or 15.24%, from the March 31, 2021, and from $64.77 or 3.41% from December 31, 2021. 1st Quarter 2022 Highlights:Returned 1.74% on average assets and 14.87% percent on average tangible common equity Annualized loan growth of 16.76%, or $38.3 million, during the quarter (excluding PPP) Continued strong asset quality, with a net recovery realized in the first 3 months of 2022 Annualized...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.